Novel 7α-alkoxy-17α-(4′-halophenylethynyl)estradiols as potential SPECT/PET imaging agents for estrogen receptor expressing tumours: Synthesis and binding affinity evaluation

Add time:08/23/2019    Source:sciencedirect.com

In order to develop potential radiolabelled probes for imaging estrogen receptor (ER) positive tumours, we have synthesized and characterized a series of novel 7α-alkoxy-17α-(4′-iodophenylethynyl)estra-1,3,5(10)-triene-3,17β-diols and 7α-alkoxy-17α-(4′-fluorophenylethynyl)estra-1,3,5(10)-triene-3,17β-diols. The fluoro-substituted compounds showed a higher ER binding affinity than the corresponding iodo-derivatives, where 7α-methoxy- and 17α-(4′-fluorophenylethynyl)estra-1,3,5(10)-triene-3,17β-diol showed the highest ER binding affinities (RBA = 80.9% and 78.9%, respectively), among the halophenylethynyl compounds studied and should be further explored as potential PET biomarkers for imaging of ER expressing tumours.

We also recommend Trading Suppliers and Manufacturers of 3-Methoxy-7α-Methyl-estra-2,5(10)-dien-17β-ol (cas 15506-02-2). Pls Click Website Link as below: cas 15506-02-2 suppliers

Prev:Optimization of the alkyl side chain length of fluorine-18-labeled 7α-alkyl-fluoroestradiol
Next:NotePseudo-oxocarbon complexes — crystal structure of a copper(II) complex with 2,4-bis(dicyanomethylene)cyclobutane-1,3-dione (cas 15506-53-3))